menu search

MDXHF / MedX Health says its SIAscopy/DermSecure products show significant promise as it reports Q1 results

MedX Health says its SIAscopy/DermSecure products show significant promise as it reports Q1 results
MedX Health Corp. (TSX-V:MDX) has said its SIAscopy and DermSecure products have shown significant promise with the signing of commercial agreements for their deployment, which should provide a solid revenue base for the rest of the year. The paid pilot-to-commercial agreements consist of confirmed sales of 80 units, currently being deployed, and an option for 40 more units to be confirmed by the fourth quarter of 2022. Read More
Posted: May 31 2022, 08:19
Author Name: Proactive Investors
Views: 112578

MDXHF News  

MDXH Stock: 38.06% Fall Explained

By Pulse2
February 6, 2023

MDXH Stock: 38.06% Fall Explained

The stock price of MDxHealth SA (MDXH) fell by 38.06% in the most recent trading session. This is why. more_horizontal

MedX Health says its SIAscopy/DermSecure products show significant promise as it reports Q1 results

By Proactive Investors
May 31, 2022

MedX Health says its SIAscopy/DermSecure products show significant promise as it reports Q1 results

MedX Health Corp. (TSX-V:MDX) has said its SIAscopy and DermSecure products have shown significant promise with the signing of commercial agreements more_horizontal

MedX signs distribution agreement with Vitamed Biomedical to launch its teledermatology screening platform in Italy

By Proactive Investors
April 4, 2022

MedX signs distribution agreement with Vitamed Biomedical to launch its teledermatology screening platform in Italy

MedX Health Corp. (TSX-V:MDX) said it has signed a commercial distribution agreement with Vitamed Biomedical s.r.l. to launch its teledermatology scr more_horizontal

MedX Health appoints healthcare veteran Naman Demaghlatrous as its new CEO

By Proactive Investors
March 23, 2022

MedX Health appoints healthcare veteran Naman Demaghlatrous as its new CEO

MedX Health Corp. (TSX-V:MDX) has announced the appointment of Naman Demaghlatrous as the company's new president and CEO, effective immediately. MedX more_horizontal

MedX Health closes first tranche of the non-brokered private placement with the issuance of 20 convertible loan notes which raised a total of $1M

By Proactive Investors
March 22, 2022

MedX Health closes first tranche of the non-brokered private placement with the issuance of 20 convertible loan notes which raised a total of $1M

MedX Health Corp said it has closed the first tranche of the non-brokered private placement it announced on March 1, 2022, with the issuance of 20 co more_horizontal

MedX Health strikes agreement with Health Partners to launch tele dermatology screening platform in the UK

By Proactive Investors
March 2, 2022

MedX Health strikes agreement with Health Partners to launch tele dermatology screening platform in the UK

MedX Health Corp, a leader in tele dermatology, has announced a Memorandum of Understanding (MOU) and the launch of a new commercialization pilot proj more_horizontal

MedX Health strikes agreement with Health Partners to launch tele dermatology screening platform in the UK

By Proactive Investors
March 2, 2022

MedX Health strikes agreement with Health Partners to launch tele dermatology screening platform in the UK

MedX Health Corp, a leader in tele dermatology, has announced a Memorandum of Understanding (MOU) and the launch of a new commercialization pilot proj more_horizontal

MedX Health strikes agreement with Health Partners to launch tele dermatology screening platform in the UK

By Proactive Investors
March 2, 2022

MedX Health strikes agreement with Health Partners to launch tele dermatology screening platform in the UK

MedX Health Corp, a leader in tele dermatology, has announced a Memorandum of Understanding (MOU) and the launch of a new commercialization pilot proj more_horizontal


Search within

Pages Search Results: